I think in the long term for the UK, the move with AZ still makes sense for all the short term wrangling and pain. At the end of the day AZ is still going to be the most widely deployed vaccine in the world, admittedly in part due to the efforts of SII.Calculon wrote: ↑Tue Mar 30, 2021 9:41 am Good piece on AZ in the bbc
https://www.bbc.com/news/business-56570364
With hindsight would probably have been better for Oxford to partner with Merck to develop their vaccine rather than AZ.
But the work with AZ, when seen in conjunction with the investments in the VMIC in Harwell and CGT Catapult in Braintree are part of a far broader investment and development strategy for the UK, both for long term security but also inwards capital investment